191 related articles for article (PubMed ID: 18690990)
1. The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
McAfee AT; Holdridge KC; Johannes CB; Hornbuckle K; Walker AM
Curr Drug Saf; 2008 May; 3(2):123-31. PubMed ID: 18690990
[TBL] [Abstract][Full Text] [Related]
2. A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications.
McAfee AT; Landon J; Jones M; Bangs ME; Acharya N; Hornbuckle K; Wong J
Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):386-93. PubMed ID: 23280590
[TBL] [Abstract][Full Text] [Related]
3. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.
Peterson K; McDonagh MS; Fu R
Psychopharmacology (Berl); 2008 Mar; 197(1):1-11. PubMed ID: 18026719
[TBL] [Abstract][Full Text] [Related]
4. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine.
Wernicke JF; Holdridge KC; Jin L; Edison T; Zhang S; Bangs ME; Allen AJ; Ball S; Dunn D
Dev Med Child Neurol; 2007 Jul; 49(7):498-502. PubMed ID: 17593120
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
Santosh PJ; Sattar S; Canagaratnam M
CNS Drugs; 2011 Sep; 25(9):737-63. PubMed ID: 21870887
[TBL] [Abstract][Full Text] [Related]
6. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.
Eiland LS; Bell EA; Erramouspe J
Ann Pharmacother; 2014 Oct; 48(10):1350-5. PubMed ID: 24982313
[TBL] [Abstract][Full Text] [Related]
7. Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database.
McCarthy S; Cranswick N; Potts L; Taylor E; Wong IC
Drug Saf; 2009; 32(11):1089-96. PubMed ID: 19810780
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
Stuhec M; Munda B; Svab V; Locatelli I
J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with initiation with atomoxetine versus stimulants in the treatment of adults with ADHD: retrospective analysis of administrative claims data.
Van Brunt DL; Johnston JA; Ye W; Pohl GM; O'Hara NN
J Manag Care Pharm; 2006 Apr; 12(3):230-8. PubMed ID: 16623607
[TBL] [Abstract][Full Text] [Related]
10. ADHD update: new data on the risks of medication.
Harv Ment Health Lett; 2006 Oct; 23(4):3-5. PubMed ID: 17183739
[No Abstract] [Full Text] [Related]
11. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
[TBL] [Abstract][Full Text] [Related]
12. [Atomoxetine in ADHD: caution].
Karila L
Rev Prat; 2011 Nov; 61(9 Suppl):S7-8. PubMed ID: 22338199
[No Abstract] [Full Text] [Related]
13. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
Lindemann C; Langner I; Kraut AA; Banaschewski T; Schad-Hansjosten T; Petermann U; Petermann F; Schreyer-Mehlhop I; Garbe E; Mikolajczyk RT
J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):307-14. PubMed ID: 22856384
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
[TBL] [Abstract][Full Text] [Related]
15. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
16. Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.
Kornfield R; Watson S; Higashi AS; Conti RM; Dusetzina SB; Garfield CF; Dorsey ER; Huskamp HA; Alexander GC
Psychiatr Serv; 2013 Apr; 64(4):339-46. PubMed ID: 23318985
[TBL] [Abstract][Full Text] [Related]
17. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
[TBL] [Abstract][Full Text] [Related]
18. The incidence of first provoked and unprovoked seizure in pediatric patients with and without psychiatric diagnoses.
McAfee AT; Chilcott KE; Johannes CB; Hornbuckle K; Hauser WA; Walker AM
Epilepsia; 2007 Jun; 48(6):1075-82. PubMed ID: 17441988
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M
Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dystonia in children and adolescents treated with atomoxetine within the Truven MarketScan database: a retrospective cohort study.
Meyers KJ; Upadhyaya HP; Goodloe R; Kryzhanovskaya LA; Liles-Burden MA; Kellier-Steele NA; Mancini M
Expert Opin Drug Saf; 2018 May; 17(5):467-473. PubMed ID: 29625537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
